Question 1

Does BlackRock own PTGX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BlackRock holds 10,307,837 shares of PTGX (Protagonist Therapeutics), worth $1.3B.

Question 2

How many shares of PTGX does BlackRock own?

Accepted Answer

As of its Q2 2026 13F, BlackRock holds 10,307,837 shares of PTGX (Protagonist Therapeutics).

Question 3

What is BlackRock's PTGX position worth?

Accepted Answer

As of its Q2 2026 13F, BlackRock's PTGX position is worth $1.3B.

Question 4

Is BlackRock buying or selling PTGX?

Accepted Answer

In Q2 2026, BlackRock increased its PTGX position by 528,468 shares (+5.4%).

Question 5

When did BlackRock first buy PTGX?

Accepted Answer

BlackRock already held PTGX in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	10.3M	+5.4%	$1.3B	0.0%	$122.58	34
2026-Q1	Increased	9.8M	+0.7%	$1B	0.0%	$105.40	32
2025-Q4	Increased	9.7M	+3.3%	$848.6M	0.0%	$87.34	33
2025-Q3	Decreased	9.4M	-2.4%	$624.7M	0.0%	$66.43	0
2025-Q2	Decreased	9.6M	-1.1%	$532.3M	0.0%	$55.27	0
2025-Q1	Decreased	9.7M	-1.5%	$470.9M	0.0%	$48.36	0
2024-Q4	Decreased	9.9M	-3.3%	$381.5M	0.0%	$38.60	0
2024-Q3	First report	10.2M	-	$460.1M	0.0%	$45.00	0

PTGX8 quarters

PTGX
8 quarters